Since its establishment in 2006, the Gastroparesis Clinical Research Consortium (GpCRC), a multi-center coalition created and funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has made major advances to our understanding of the pathophysiology of Gastroparesis (Gp).
Through the establishment of the largest gastroparesis tissue repository in the United States, combined with detailed phenotypic data, the GpCRC is ideally suited to accelerate insights into the underlying cellular and molecular pathophysiology of the gastroparesis with the ultimate goal of developing therapeutic target(s).
This RFA invites investigators from several disciplines, including basic and translational research in areas of neurosciences, immunology, microbiology and physiology, to contribute new insights into the cellular and molecular mechanisms of Gastroparesis.
Only one application per institution is allowed.
Deadlines:
Letter of Intent Due Date(s): February 3, 2021
Application Due Date(s): March 3, 2021
RFA-DK-20-030 Expiration Date March 4, 2021
Application budgets are limited to $250,000 in direct costs per year. Application budgets should reflect the actual needs of the proposed project.
The maximum project period is 5 years.
